Sponsor of the Day:
Jerkmate
https://www.helus.com/hlp003/
HLP003 - Helus
Jan 21, 2026 - CYB003, a deuterated compound with FDA Breakthrough Therapy Designation, is in clinical trials for adjunctive treatment of Major Depressive Disorder.
helus
https://www.statnews.com/2026/03/31/biotech-news-psychedelic-startups-face-scrutiny-over-youtube-promo/
Eli Lilly, Apellis, Gilead, Helus Pharma: Readout Newsletter
Mar 31, 2026 - Today's biotech news covers Biogen and Eli Lilly making takeover moves, Doctors Without Borders slamming Gilead, and more
eli lillyhelus pharmareadout newsletterapellisgilead
https://www.helus.com/
Welcome to Helus Pharma
Apr 20, 2026 - Helus is advancing mental health treatments through novel, second-generation therapies, proprietary drug delivery systems, and patent-protected molecules.
helus pharmawelcome
https://www.investorbrandnetwork.com/clients/helus-pharma-inc/
Helus Pharma Inc. (NASDAQ: HELP) (NEO: HELP) - IBN (InvestorBrandNetwork)
Feb 12, 2026 - Disseminated on behalf of Helus Pharma Inc., may include paid advertisements. Investment Considerations Helus Pharma Inc. (NASDAQ: HELP) (NEO: HELP),...
helus pharmainc nasdaqibn investorbrandnetworkhelpneo
https://www.helus.com/development-pipeline/
Development Pipeline - Helus
Mar 16, 2026 - Helus’ development pipeline advances next-gen neuropsychiatry therapies for depression and anxiety. CYB003 and CYB004 are in clinical trials with positive...
development pipelinehelus